Pathogenesis of equine herpesvirus-1 in specific pathogen-free foals: primary and secondary infections and reactivation
- PMID: 1314051
- DOI: 10.1007/BF01317269
Pathogenesis of equine herpesvirus-1 in specific pathogen-free foals: primary and secondary infections and reactivation
Abstract
Six specific pathogen-free foals shown to be free of equine herpesvirus-1 and 4 (EHV-1 and -4) and lacking in maternally-derived antibodies were used to investigate the pathogenesis of EHV-1 in horses. Following primary intranasal inoculation with EHV-1 all foals showed signs of a mild, self-limiting upper respiratory tract infection. A leucopenia was observed, comprising both a lymphopenia and neutropenia. Virus was isolated from nasal mucus and buffy coat cells over several days during the clinical episode and after the animals became clinically normal. Notwithstanding the mildness of the clinical disease, virus was not eliminated completely and intravenous administration of dexamethasone resulted in reactivation of latent EHV-1 in animals which had received only a single dose of the virus. In a second infection given to four foals, 61 days after the primary inoculation, no clinical signs were observed, haematological changes were minimal and viraemia was absent.
Similar articles
-
Equid herpesvirus (EHV-1) live vaccine strain C147: efficacy against respiratory diseases following EHV types 1 and 4 challenges.Vet Microbiol. 2003 Mar 20;92(1-2):1-17. doi: 10.1016/s0378-1135(02)00358-9. Vet Microbiol. 2003. PMID: 12488066
-
Serological responses of specific pathogen-free foals to equine herpesvirus-1: primary and secondary infection, and reactivation.Vet Microbiol. 1992 Oct;32(3-4):199-214. doi: 10.1016/0378-1135(92)90145-j. Vet Microbiol. 1992. PMID: 1333670
-
Efficacy of a live equine herpesvirus-1 (EHV-1) strain C147 vaccine in foals with maternally-derived antibody: protection against EHV-1 infection.Equine Vet J. 2004 Jul;36(5):447-51. doi: 10.2746/0425164044868332. Equine Vet J. 2004. PMID: 15253088
-
A review of equid herpesvirus 1 for the veterinary practitioner. Part A: clinical presentation, diagnosis and treatment.N Z Vet J. 2014 Jul;62(4):171-8. doi: 10.1080/00480169.2014.899945. N Z Vet J. 2014. PMID: 24597778 Review.
-
Recent advancements in our understanding of equid gammaherpesvirus infections.Equine Vet J. 2022 Jan;54(1):11-23. doi: 10.1111/evj.13512. Epub 2021 Oct 1. Equine Vet J. 2022. PMID: 34519074 Review.
Cited by
-
Access to a main alphaherpesvirus receptor, located basolaterally in the respiratory epithelium, is masked by intercellular junctions.Sci Rep. 2017 Nov 30;7(1):16656. doi: 10.1038/s41598-017-16804-5. Sci Rep. 2017. PMID: 29192251 Free PMC article.
-
EHV-1: A Constant Threat to the Horse Industry.Front Microbiol. 2019 Dec 3;10:2668. doi: 10.3389/fmicb.2019.02668. eCollection 2019. Front Microbiol. 2019. PMID: 31849857 Free PMC article. Review.
-
Immunization with glycoprotein C of equine herpesvirus-1 is associated with accelerated virus clearance in a murine model.Arch Virol. 1995;140(4):789-97. doi: 10.1007/BF01309967. Arch Virol. 1995. PMID: 7794119
-
In situ study on the pathogenesis and immune reaction of equine herpesvirus type 1 (EHV-1) infections in mice.Immunology. 1998 Mar;93(3):329-34. doi: 10.1046/j.1365-2567.1998.00451.x. Immunology. 1998. PMID: 9640242 Free PMC article.
-
Viremia and nasal shedding for the diagnosis of equine herpesvirus-1 infection in domesticated horses.J Vet Intern Med. 2024 May-Jun;38(3):1765-1791. doi: 10.1111/jvim.16958. Epub 2023 Dec 9. J Vet Intern Med. 2024. PMID: 38069548 Free PMC article. Review.